Please cite this paper as: Azziz‐Baumgartner et al. (2012) Incidence of influenza‐associated mortality and hospitalizations in Argentina during 2002–2009. Influenza and Other Respiratory Viruses DOI: 10.1111/irv.12022.
Background We estimated rates of influenza‐associated deaths and hospitalizations in Argentina, a country that recommends annual influenza vaccination for persons at high risk of complications from influenza illness.
Methods We identified hospitalized persons and deaths in persons diagnosed with pneumonia and influenza (P&I, ICD‐10 codes J10‐J18) and respiratory and circulatory illness (R&C, codes I00‐I99 and J00‐J99). We defined the influenza season as the months when the proportion of samples that tested positive for influenza exceeded the annual median. We used hospitalizations and deaths during the influenza off‐season to estimate, using linear regression, the number of excess deaths that occurred during the influenza season. To explore whether excess mortality varied by sex and whether people were age <65 or ≥65 years, we used Poisson regression of the influenza‐associated rates.
Results During 2002–2009, 2411 P&I and 8527 R&C mean excess deaths occurred annually from May to October. If all of these excess deaths were associated with influenza, the influenza‐associated mortality rate was 6/100 000 person‐years (95% CI 4–8/100 000 person‐years for P&I and 21/100 000 person‐years (95% CI 12–31/100 000 person‐years) for R&C. During 2005–2008, we identified an average of 7868 P&I excess hospitalizations and 22 994 R&C hospitalizations per year, resulting in an influenza‐associated hospitalization rate of 2/10 000 person‐years (95% CI 1–3/10 000 person‐years) for P&I and 6/10 000 person‐years (95% CI 3–8/10 000 person‐years) for R&C.
Conclusion Our findings suggest that annual rates of influenza‐associated hospitalizations and death in Argentina were substantial and similar to neighboring Brazil.
IntroductionWhile there is much information about the burden of influenza A(H1N1)pdm09 in North America, little data exist on its burden in South America.MethodsDuring April to December 2009, we actively searched for persons with severe acute respiratory infection and influenza-like illness (ILI) in three sentinel cities. A proportion of case-patients provided swabs for influenza testing. We estimated the number of case-patients that would have tested positive for influenza by multiplying the number of untested case-patients by the proportion who tested positive. We estimated rates by dividing the estimated number of case-patients by the census population after adjusting for the proportion of case-patients with missing illness onset information and ILI case-patients who visited physicians multiple times for one illness event.ResultsWe estimated that the influenza A(H1N1)pdm09 mortality rate per 100,000 person-years (py) ranged from 1.5 among persons aged 5–44 years to 5.6 among persons aged ≥65 years. A(H1N1)pdm09 hospitalization rates per 100,000 py ranged between 26.9 among children aged <5 years to 41.8 among persons aged ≥65 years. Influenza A(H1N1)pdm09 ILI rates per 100 py ranged between 1.6 among children aged <5 to 17.1 among persons aged 45–64 years. While 9 (53%) of 17 influenza A(H1N1)pdm09 decedents with available data had obesity and 7 (17%) of 40 had diabetes, less than 4% of surviving influenza A(H1N1)pdm09 case-patients had these pre-existing conditions (p≤0.001).ConclusionInfluenza A(H1N1)pdm09 caused a similar burden of disease in Argentina as in other countries. Such disease burden suggests the potential value of timely influenza vaccinations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.